询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
Ethyl cyclohexanecarboxylate | CAS:3289-28-9
Ethyl cyclohexanecarboxylate
  • 名称:环己甲酸乙酯 | Ethyl cyclohexanecarboxylate
  • CAS号:3289-28-9
  • 别名:Cyclohexanecarboxylic acid ethyl ester
  • 分子式:C9H16O2
  • 分子量:156.22
  • EINESC号:221-945-7

产品描述

物理化学性质

没有数据没有数据

安全数据

没有数据没有数据

SDS

来源 SDS样本
Alfa-Aesar 浏览或下载
Combi-Blocks 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Species differences and substrate specificity of CYP3A heteroactivation by efavirenz.Yohei Kosugi et al.Xenobiotica; the fate of foreign compounds in biological systems, 45(4), 345-352 (2014-11-12) Enhancement of CYP3A4 activity in Hep G2 cells by lentiviral transfection of hepatocyte nuclear factor-1 alpha.Tsai-Shin Chiang et al.PloS one, 9(4), e94885-e94885 (2014-04-16) Interactions of endosulfan and methoxychlor involving CYP3A4 and CYP2B6 in human HepaRG cells.Camille C Savary et al.Drug metabolism and disposition: the biological fate of chemicals, 42(8), 1235-1240 (2014-05-17) Occurrence and measurement of nifedipine and its nitropyridine derivatives in human blood plasma.J Dokladalova et al.Journal of chromatography, 231(2), 451-458 (1982-09-10) The first pass metabolism of nifedipine in man.D G Waller et al.British journal of clinical pharmacology, 18(6), 951-954 (1984-12-01) Structure-function analysis of porcine cytochrome P450 3A29 in the hydroxylation of T-2 toxin as revealed by docking and mutagenesis studies.Guyue Cheng et al.PloS one, 9(9), e106769-e106769 (2014-09-04) Isotopic sensitivity in the microsomal oxidation of the dihydropyridine calcium entry blocker nifedipine.J L Born et al.Chemical research in toxicology, 2(1), 57-59 (1989-01-01) Da-Chaihu-Tang alters the pharmacokinetics of nifedipine in rats and a treatment regimen to avoid this.Ju-Xiu He et al.The Journal of pharmacy and pharmacology, 66(11), 1623-1630 (2014-06-26) Delamanid does not inhibit or induce cytochrome p450 enzymes in vitro.Yoshihiko Shimokawa et al.Biological & pharmaceutical bulletin, 37(11), 1727-1735 (2014-11-05)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交